parkinson glutathione oxidative ipsc In vivo and in vitro perspectives in Parkinson's disease: Mechanisms and the role of phytomedicine Nrf2–Keap1 Pathway and NLRP3 Inflammasome
Nrf2Keap1 Pathway and NLRP3 Inflammasome in Parkinson's Disease: Mechanistic Crosstalk and Therapeutic Implications Molecular Neurobiology Springer Nature Link Glutathione S transferase: A keystone in Parkinson's disease pathogenesis and therapy ScienceDirect Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Cell Death & Disease Diverging Parkinson's Disease Pathology between patient derived GBAN370S, LRRK2G2019S and engineered SNCAA53T iPSC derived Dopaminergic Neurons bioRxiv Targeting Ferroptosis in Parkinson's Disease: Mechanisms and Emerging Therapeutic Strategies
Pay in 4 interest-free payments of $7.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21




